At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 18 enrolled
Drug / intervention
Inosinedrug
Likely dose
Inosine 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effects of Food on the Pharmacokinetics of Urate After a Single Dose of Inosine in Healthy Male Subjects
In Brief
A Phase 1 clinical trial evaluating Inosine for Healthy. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effects of food on the amount of urate in the body after a single oral dose of inosine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedNov 2015
Primary CompletionApr 2016
Study CompletionMay 2016
TodayJul 2026
First PostedNov 25, 2015
Enrollment StartMar 1, 2015
Primary CompletionApr 1, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.6 years ago
Interventions
Inosinedrug
Inosine, 1000 mg